Eye drop trial aims to halt worsening vision in kids
NCT ID NCT07329777
Summary
This study is testing whether low-dose atropine eye drops can safely slow the progression of nearsightedness in children. Researchers will compare the drops to a placebo in 144 children aged 5-10 over two years. The goal is to find a treatment that can help control worsening vision and reduce the risk of future serious eye problems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOPIA PROGRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Pakar Kanak-Kanak UKM
RECRUITINGKuala Lumpur, Cheras, 56000, Malaysia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Universiti Malaya Medical Centre
RECRUITINGKuala Lumpur, Petaling Jaya, 50603, Malaysia
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.